Third quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session. Friday October 25, 2024 14:00 - 15:30 CET ...

Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session. I am encouraged by the ...

Les résultats du troisième trimestre 2024 ont été commentés par le management au cours d'une téléconférence avec la communauté financière le vendredi 25 octobre 2024. La présentation a été suivie ...

Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement ...

Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Dupixent significantly reduced itch and hive activity from baseline; 41% of patients ...

Sanofi US (Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.) respects the interest that visitors to our websites have in understanding what information is collected electronically, how it is ...

Our manufacturing sites are state-of-the-art, powered by big data and digital. It is by producing vaccines that our mission takes on its full meaning. It is the bridge between scientific advances and ...

Mission: to design our clinical trials to be inclusive and more representative of the populations who are most likely to benefit from our medicines. Vision: we envision a future where inclusivity is ...

For over 100 years, we have been protecting the health of millions. But an additional 1.5 million lives could be saved each year with improved vaccination coverage (1). We are often unaware of the ...

We want to improve the lives of millions of people who don’t have access to the help they need. To do that, we’re expanding our health-system partnerships at local, regional, and global levels.

At Sanofi, we’re proud to be premium partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further, and to never, ever settle ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain ...